Moricandia Extract for Insulin Sensitivity and Glucose Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for metabolic diseases related to glucose intolerance and insulin resistance, such as type 2 diabetes, metabolic syndrome, and obesity, are associated with significant side effects and do not effectively address the underlying metabolic dysregulation.
Innovation Solution
A composition comprising an extract of Moricandia and/or Astragalus, specifically Moricandia arvensis and/or Astragalus armatus, which is administered through decoction or maceration, is used to prevent and treat metabolic diseases by improving insulin sensitivity, reducing glucose intolerance, and controlling weight gain.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments (insulin, sulfonylureas, biguanides, α-glucosidase inhibitors, thiazolidinediones) are used to treat metabolic diseases, then glucose control is improved, but side effects and harmful factors increase
Solution Approach 1:
The patent employs plant extracts (Moricandia and Astragalus) as natural, biodegradable alternatives to conventional pharmaceuticals. These natural compounds offer a safer profile with fewer side effects while maintaining therapeutic effectiveness for glucose control, representing a substitution of harmful synthetic drugs with benign natural substances
Solution Approach 2:
The patent modifies the chemical composition parameters by using standardized extracts with specific active compounds (e.g., chlorogenic acid, caffeic acid, quercetin) in controlled concentrations. This parameter standardization ensures consistent therapeutic effects while maintaining safety, addressing both effectiveness and safety concerns simultaneously
2Reliability
If conventional treatments are used to manage insulin resistance, then glycemic deregulation is addressed, but dependency on insulin and complex treatment regimens increase
Solution Approach 1:
The plant extracts exhibit multi-functional effects including improving insulin sensitivity, reducing glucose intolerance, and modulating metabolic parameters simultaneously. This multi-action approach simplifies treatment by replacing multiple specialized drugs with a single natural supplement that addresses multiple aspects of metabolic dysfunction
Solution Approach 2:
The extracts promote endogenous insulin production and improve the body's natural metabolic regulation mechanisms. By stimulating the pancreas to produce sufficient insulin and improving tissue sensitivity, the treatment enables the body to self-regulate glucose metabolism without requiring external insulin therapy or complex monitoring regimens
3Reliability
If weight loss treatments are used to control obesity, then fat mass is reduced, but harmful factors and side effects increase
Solution Approach 1:
The patent uses natural plant compounds that promote healthy weight loss through metabolic regulation rather than aggressive fat destruction. These gentle, natural agents reduce fat mass while preserving lean tissue and avoiding the severe side effects associated with conventional weight loss drugs, offering a safe alternative for obesity management
Data Source
AI summary
A composition including an extract of Moricandia for the use thereof in the prevention and/or treatment of metabolic diseases related to impaired glucose tolerance and/or insulin resistance. Also a composition including an extract of Moricandia for the use thereof in the prevention of weight gain, in particular of body fat.